Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 6 Active not recruiting 3 Terminated 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 36 Plasma cell 24 Other hematologic neoplasm 7 Myeloid 3 Gastrointestinal 2 Dermatologic 2 Tumor-Agnostic 1 Thoracic 1 Sarcoma 1 Other solid neoplasm 1 Head & Neck 1 CNS 1

Conditions

Neuroblastoma 1

Interventions

Temozolomide 66 Radiotherapy 52 Carboplatin 25 Bevacizumab 21 Cisplatin 19 Radiosurgery 18 Vincristine 17 Etoposide 17 Cyclophosphamide 17 Surgical Procedures, Operative 13 Magnetic Resonance Spectroscopy 13 Chemotherapy, Adjuvant 11 Melphalan 10 Lomustine 10 Drug Therapy 10 Filgrastim 9 Erlotinib Hydrochloride 9 apatinib 8 Pemetrexed 8 3-Iodobenzylguanidine 8 anlotinib 7 Radiation 7 Peripheral Blood Stem Cell Transplantation 7 Methotrexate 7 Thiotepa 6 Isotretinoin 6 Irinotecan 6 Ifosfamide 6 Doxorubicin 6 Carmustine 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Lenalidomide × CNS × Clear all

NCT04049864 2022-03-02

DNA Vaccination Against Neuroblastoma

Belarusian Research Center for Pediatric Oncology, Hematology and Immunology

Phase EARLY_PHASE1 Unknown

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡